Skip to main content

Table 4 Features of potential DDIs (1510)

From: A comprehensive evaluation of potentially significant drug-drug, drug-herb, and drug-food interactions among cancer patients receiving anticancer drugs

No. of potential DDIs per subject (N = 327)

  No interactions

39 (11.9)

  1–2

89 (27.2)

  3–4

69 (21.1)

  5–6

42 (12.8)

   > 6

88 (26.9)

Severity

  Minor

424 (28.1)

  Moderate

857 (56.8)

  Major

199 (13.2)

  N/A

30 (2.0)

Risk rating

  A

30 (2.0)

  B

427 (28.3)

  C

845 (56.0)

  D

168 (11.1)

  X

40 (2.6)

Reliability

  Poor

21 (1.4)

  Fair

1044 (69.1)

  Good

395 (26.2)

  Excellent

50 (3.3)